Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christine A. Byrnes"'
Autor:
Steven T. Harris, Charles Liss, Mary E. Melton, Brian W. Walsh, Christine A. Byrnes, Jane E. Reagan, Robert Lindsay, Felicia Cosman, Rogerio A. Lobo
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:3076-3081
Alendronate and estrogen are effective therapies for postmenopausal osteoporosis, but their efficacy and safety as combined therapy are unknown. The objective of this study was to evaluate the addition of alendronate to ongoing hormone replacement th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3014cd2d116542467a6161841a405db6
https://doi.org/10.1210/jcem.84.9.5989
https://doi.org/10.1210/jcem.84.9.5989
Publikováno v:
Prostate Cancer and Prostatic Diseases. 1:26-31
The purpose of this paper is to examine effects of finasteride 5 mg across different age groups in an ethnically diverse population of men with symptomatic benign prostatic hyperplasia (BPH) seen in community urology and primary care practices. Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b9200e2027d5e395727552298153d8
https://doi.org/10.1038/sj.pcan.4500202
https://doi.org/10.1038/sj.pcan.4500202
Publikováno v:
Clinical Therapeutics. 19:243-258
Because increasing numbers of men are seeking treatment for benign prostatic hyperplasia (BPH) from primary care physicians, we sought to assess the efficacy and tolerability of finasteride in a primary care setting. In this randomized, double-masked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2623cda5881935dcfed06df485ae9d82
https://doi.org/10.1016/s0149-2918(97)80113-0
https://doi.org/10.1016/s0149-2918(97)80113-0
Publikováno v:
Clinical Therapeutics. 17:956-969
This study sought to assess the efficacy, tolerability, and effect of finasteride on health-related quality of life (HRQL) in a diverse population of men with moderate-to-severe symptomatic benign prostatic hyperplasia (BPH). This double-blind study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9126e39417c2dfd3564a1ac076fc822e
https://doi.org/10.1016/0149-2918(95)80073-5
https://doi.org/10.1016/0149-2918(95)80073-5
Autor:
Philip D. Ross, Huibert A. P. Pols, Jennifer Turpin, Piet Geusens, Danny J M van der Voort, Christine A. Byrnes, Marjolein van der Klift, Marc C. Hochberg, Ethel S. Siris, Mary E. Melton
Publikováno v:
Mayo Clinic proceedings. 77(7)
Objective To examine the ability of 4 published osteoporosis risk indices to identify women with low bone density. Subjects and Methods : Subjects included postmenopausal women 45 years and older consecutively recruited from US clinics, women from ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05f5955631553a2fd3b92d7de536d694
https://pubmed.ncbi.nlm.nih.gov/12108598
https://pubmed.ncbi.nlm.nih.gov/12108598
Autor:
Mary E. Melton, Steven T. Harris, Charles Liss, Brian W. Walsh, Christine A. Byrnes, Rogerio A. Lobo, Robert Lindsay, Jane E. Reagan, Felicia Cosman
Publikováno v:
Climacteric. 2:290-291
Alendronate and estrogen are effective therapies for postmenopausal osteoporosis, but their efficacy and safety as combined therapy are unknown. The objective of this study was to evaluate the addition of alendronate to ongoing hormone replacement th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b879d981bbc1fdced6b8e54f24e2397f
https://doi.org/10.3109/13697139909038095
https://doi.org/10.3109/13697139909038095
Publikováno v:
Clinical Therapeutics. 18:22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d93dcfae02fc84a709cf5a45ad28cc0c
https://doi.org/10.1016/s0149-2918(96)80116-0
https://doi.org/10.1016/s0149-2918(96)80116-0